IP Library › Granted Patent US 10,688,220
Granted Patent B2
US 10,688,220 · App. 14/896,147 · Granted Jun 23, 2020

Amniotic membrane

Inventors: Andrew Hopkinson (Nottingham, GB); Matthew Branch (Nottingham, GB); Harminder Dua (Nottingham, GB); Claire Allen (Nottingham, GB)
Assignee: THE UNIVERSITY OF NOTTINGHAM
A61L27/3691A61L27/3604A61L27/3641A61L27/3687A61L27/505A61L27/54A61L2430/16
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,688,220
App. No.
14/896,147
Granted
Jun 23, 2020
Kind
B2
Abstract

The invention relates to a preserved amniotic membrane, in particular a vacuum-dried amniotic membrane. It also relates to uses of vacuum-dried amniotic membrane and methods for making a vacuum-dried amniotic membrane. A method of processing an amniotic membrane to provide a vacuum-dried amniotic membrane, comprising the step of vacuum-drying the amniotic membrane Amniotic membrane (AM) is the inner most extraembryonic membrane that surrounds the foetus in a sac of amniotic fluid, functioning as a protective barrier to ascending infection and trauma during pregnancy.

Claims (12)

1. A method of processing an amniotic membrane to provide a vacuum-dried amniotic membrane comprising the step of vacuum-drying the amniotic membrane, wherein the membrane is not frozen before or during the vacuum-drying step, and wherein when the membrane is reconstituted the membrane preparation releases epidermal growth factor (EGF) for a period of two or more days.

2. The method of claim 1 wherein the membrane is treated with one or more lyoprotectants before vacuum-drying.

3. The method according to claim 2 wherein the one or more lyoprotectant are selected from trehalose and raffinose.

4. The method of claim 1 wherein the lyoprotectant is trehalose or raffinose in combination with one or more further lyoprotectants.

5. The method of claim 1 wherein the amniotic membrane is treated with an antioxidant before vacuum-drying.

6. The method according to claim 5 wherein the antioxidant is epigallocatechin.

7. The method of claim 1 wherein the amniotic membrane is treated with further preservatives before the vacuum-drying step.

8. The method of claim 1 wherein the amniotic membrane is treated with thermolysin before vacuum-drying to provide a denuded amniotic membrane.

9. The method according to claim 8 further comprising the step of seeding cells onto the denuded amniotic membrane before vacuum-drying or after reconstituting the membrane.

10. A vacuum-dried amniotic membrane prepared using by the method according to claim 1 .

11. A denuded vacuum-dried amniotic membrane prepared by the method according to claim 8 .

12. A method of treating diseases or injuries of the eye comprising the step of applying a vacuum-dried amniotic membrane prepared by the method of claim 1 to the eye.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 18, 2016
From: HOPKINSON, ANDREW; BRANCH, MATTHEW; DUA, HARMINDER; ALLEN, CLAIRE
To: THE UNIVERSITY OF NOTTINGHAM
Reel/Frame 039726/0475 →
Priority Claims (1)
GB 1309963.5 · Jun 4, 2013 · national
Continuity (1)
Related Publication 20160129154A1 · May 12, 2016
Cited By (3)
US 12,397,086 US 12,508,349 US 12,551,510